Other recent trades (not part of the Oncology-Biotech Portfolio):
MEDX open long Oct 28 @8.22, closed Nov 4 @9.30, profit 13.1%
GERN open long Oct 28 @8.74, closed Nov 4 @9.05, profit 3.5%
AMGN open long Oct 31 @75.96, position is still open (11-Nov closing price 81.10)
I am very happy with the system so far. Of course, two weeks is too short period of time. But it is good to see that 3 out of 4 positions are very positive and only one is flat (CEGE). AMGN entry was predicted by a separate approach that relies on Elliott Waves.
Saturday, November 12, 2005
Oncology-Biotech Portfolio Update
Other recent trades (not part of the Oncology-Biotech Portfolio):
MEDX open long Oct 28 @8.22, closed Nov 4 @9.30, profit 13.1%
GERN open long Oct 28 @8.74, closed Nov 4 @9.05, profit 3.5%
AMGN open long Oct 31 @75.96, position is still open (11-Nov closing price 81.10)
I am very happy with the system so far. Of course, two weeks is too short period of time. But it is good to see that 3 out of 4 positions are very positive and only one is flat (CEGE). AMGN entry was predicted by a separate approach that relies on Elliott Waves.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment